Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Refractory bullous pemphigoid...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Refractory bullous pemphigoid with prurigo nodularis successfully treated with dupilumab monotherapy

Refractory bullous pemphigoid with prurigo nodularis successfully treated with dupilumab monotherapy

Bibliographic Details
Main Authors: Po-Ta Lai, Han-Chi Tseng
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Dermatologica Sinica
Online Access:http://www.dermsinica.org/article.asp?issn=1027-8117;year=2022;volume=40;issue=4;spage=237;epage=238;aulast=Lai
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.dermsinica.org/article.asp?issn=1027-8117;year=2022;volume=40;issue=4;spage=237;epage=238;aulast=Lai

Similar Items

  • Bullous pemphigoid developed after dramatic improvement of severe prurigo nodularis
    by: Tomoko Hiraiwa, et al.
    Published: (2023-08-01)
  • Abrocitinib Monotherapy for Refractory Prurigo Nodularis: Report of Two Successful Cases
    by: Liang J, et al.
    Published: (2024-08-01)
  • Bullous pemphigoid successfully treated with dupilumab
    by: Daniela de Abreu e Silva Martinez, et al.
    Published: (2024-09-01)
  • Recalcitrant prurigo nodularis after COVID‐19 vaccination and successfully treated by dupilumab
    by: Shang‐shang Wang, et al.
    Published: (2023-09-01)
  • Dupilumab for recalcitrant prurigo nodularis: Case report
    by: Joel Reis, et al.
    Published: (2022-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs